Effect of immunocompromise on metastatic cutaneous squamous cell carcinoma in the parotid and neck
Background. Our aim was to examine the effect of a compromised immune state on the outcomes in patients treated for metastatic cutaneous squamous cell carcinoma (SCC). Methods. A retrospective analysis of patients with metastatic cutaneous SCC to the parotid and neck treated at Greenlane Hospital be...
Saved in:
Published in | Head & neck Vol. 28; no. 3; pp. 244 - 248 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.03.2006
John Wiley & Sons |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background.
Our aim was to examine the effect of a compromised immune state on the outcomes in patients treated for metastatic cutaneous squamous cell carcinoma (SCC).
Methods.
A retrospective analysis of patients with metastatic cutaneous SCC to the parotid and neck treated at Greenlane Hospital between 1992 and 2002 was conducted. Outcomes were compared between immune‐competent and immunocompromised patients. A logistic regression analysis of likely risk factors for poor outcome was done.
Results.
Forty‐nine patients were identified, nine of whom were immunocompromised. All patients were treated by parotidectomy and/or neck dissection. The facial nerve was sacrificed in 42% of the patients. Thirty‐seven patients underwent postoperative radiotherapy (76%). Recurrence was significantly more common in the immunocompromised group (56% vs 28%), with higher rates of local and distant recurrence. Survival at 1 and 2 years was reduced.
Conclusion.
Immunocompromise has a significant impact on the outcome of metastatic cutaneous SCC to the parotid and neck, affecting recurrence and survival. © 2005 Wiley Periodicals, Inc. Head Neck 27: XXX–XXX, 2005 |
---|---|
AbstractList | Our aim was to examine the effect of a compromised immune state on the outcomes in patients treated for metastatic cutaneous squamous cell carcinoma (SCC).
A retrospective analysis of patients with metastatic cutaneous SCC to the parotid and neck treated at Greenlane Hospital between 1992 and 2002 was conducted. Outcomes were compared between immune-competent and immunocompromised patients. A logistic regression analysis of likely risk factors for poor outcome was done.
Forty-nine patients were identified, nine of whom were immunocompromised. All patients were treated by parotidectomy and/or neck dissection. The facial nerve was sacrificed in 42% of the patients. Thirty-seven patients underwent postoperative radiotherapy (76%). Recurrence was significantly more common in the immunocompromised group (56% vs 28%), with higher rates of local and distant recurrence. Survival at 1 and 2 years was reduced.
Immunocompromise has a significant impact on the outcome of metastatic cutaneous SCC to the parotid and neck, affecting recurrence and survival. Background. Our aim was to examine the effect of a compromised immune state on the outcomes in patients treated for metastatic cutaneous squamous cell carcinoma (SCC). Methods. A retrospective analysis of patients with metastatic cutaneous SCC to the parotid and neck treated at Greenlane Hospital between 1992 and 2002 was conducted. Outcomes were compared between immune‐competent and immunocompromised patients. A logistic regression analysis of likely risk factors for poor outcome was done. Results. Forty‐nine patients were identified, nine of whom were immunocompromised. All patients were treated by parotidectomy and/or neck dissection. The facial nerve was sacrificed in 42% of the patients. Thirty‐seven patients underwent postoperative radiotherapy (76%). Recurrence was significantly more common in the immunocompromised group (56% vs 28%), with higher rates of local and distant recurrence. Survival at 1 and 2 years was reduced. Conclusion. Immunocompromise has a significant impact on the outcome of metastatic cutaneous SCC to the parotid and neck, affecting recurrence and survival. © 2005 Wiley Periodicals, Inc. Head Neck 27: XXX–XXX, 2005 Background. Our aim was to examine the effect of a compromised immune state on the outcomes in patients treated for metastatic cutaneous squamous cell carcinoma (SCC). Methods. A retrospective analysis of patients with metastatic cutaneous SCC to the parotid and neck treated at Greenlane Hospital between 1992 and 2002 was conducted. Outcomes were compared between immune-competent and immunocompromised patients. A logistic regression analysis of likely risk factors for poor outcome was done. Results. Forty-nine patients were identified, nine of whom were immunocompromised. All patients were treated by parotidectomy and/or neck dissection. The facial nerve was sacrificed in 42% of the patients. Thirty-seven patients underwent postoperative radiotherapy (76%). Recurrence was significantly more common in the immunocompromised group (56% vs 28%), with higher rates of local and distant recurrence. Survival at 1 and 2 years was reduced. Conclusion. Immunocompromise has a significant impact on the outcome of metastatic cutaneous SCC to the parotid and neck, affecting recurrence and survival. BACKGROUNDOur aim was to examine the effect of a compromised immune state on the outcomes in patients treated for metastatic cutaneous squamous cell carcinoma (SCC).METHODSA retrospective analysis of patients with metastatic cutaneous SCC to the parotid and neck treated at Greenlane Hospital between 1992 and 2002 was conducted. Outcomes were compared between immune-competent and immunocompromised patients. A logistic regression analysis of likely risk factors for poor outcome was done.RESULTSForty-nine patients were identified, nine of whom were immunocompromised. All patients were treated by parotidectomy and/or neck dissection. The facial nerve was sacrificed in 42% of the patients. Thirty-seven patients underwent postoperative radiotherapy (76%). Recurrence was significantly more common in the immunocompromised group (56% vs 28%), with higher rates of local and distant recurrence. Survival at 1 and 2 years was reduced.CONCLUSIONImmunocompromise has a significant impact on the outcome of metastatic cutaneous SCC to the parotid and neck, affecting recurrence and survival. |
Author | Chaplin, John M. Eisenberg, Robert L. Morton, Randall P. McIvor, Nicholas P. Southwell, Katherine E. |
Author_xml | – sequence: 1 givenname: Katherine E. surname: Southwell fullname: Southwell, Katherine E. organization: Head and Neck Department, Department of Otorhinolaryngology/Head and Neck Surgery, Auckland City Hospital, Park Rd Private Bag 92024, Auckland 1, New Zealand; Greenlane Hospital, Auckland, New Zealand – sequence: 2 givenname: John M. surname: Chaplin fullname: Chaplin, John M. email: jchaplin@adhb.gout.nz organization: Head and Neck Department, Department of Otorhinolaryngology/Head and Neck Surgery, Auckland City Hospital, Park Rd Private Bag 92024, Auckland 1, New Zealand; Greenlane Hospital, Auckland, New Zealand – sequence: 3 givenname: Robert L. surname: Eisenberg fullname: Eisenberg, Robert L. organization: Head and Neck Department, Department of Otorhinolaryngology/Head and Neck Surgery, Auckland City Hospital, Park Rd Private Bag 92024, Auckland 1, New Zealand; Greenlane Hospital, Auckland, New Zealand – sequence: 4 givenname: Nicholas P. surname: McIvor fullname: McIvor, Nicholas P. organization: Head and Neck Department, Department of Otorhinolaryngology/Head and Neck Surgery, Auckland City Hospital, Park Rd Private Bag 92024, Auckland 1, New Zealand; Greenlane Hospital, Auckland, New Zealand – sequence: 5 givenname: Randall P. surname: Morton fullname: Morton, Randall P. organization: Head and Neck Department, Department of Otorhinolaryngology/Head and Neck Surgery, Auckland City Hospital, Park Rd Private Bag 92024, Auckland 1, New Zealand; Greenlane Hospital, Auckland, New Zealand |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17502430$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/16395715$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kEtv1TAQhS1URB-w4A8gbwCxSGt77DyW6HK5rVSVRXksrYljq6aJfRsngv57fMltWdHVjEbfzJxzjslBiMES8pqzU86YOLux3algIPgzcsRZUxUMZHWw6yUUwCp5SI5T-skYg1KKF-SQl9Coiqsj0q6ds2ai0VE_DHOIJg7bMQ4-WRoDHeyEacLJG2rmCYONc6LpbsZh1xjb99TgaHyIA1If6HRj6RbHOPmOYuhosOb2JXnusE_21b6ekG-f119X58Xll83F6uNlYaQAXoiaQyu5A8MdNm3HbW1ELlwZJ7rWIFpQknNpJdaAtauErVGAU63EljdwQt4vd7P-u9mmSWcXO4mLbN0wAQCi5Jl89yRZVqUq61Jl8MMCmjGmNFqnt6MfcLzXnOld9DpHr_9Gn9k3-6NzO-TpI7nPOgNv9wAmg70bMRif_nGVYkICy9zZwv3yvb3__0d9vv708LpYNnya7O_HDRxvsxWolP5xtdFscw21ul7p7_AHsd6r9w |
CitedBy_id | crossref_primary_10_1155_2007_80572 crossref_primary_10_1002_lary_24586 crossref_primary_10_1016_j_jaad_2015_04_037 crossref_primary_10_1002_cncr_24208 crossref_primary_10_1016_j_bjoms_2021_01_003 crossref_primary_10_1002_jso_21092 crossref_primary_10_1016_j_oraloncology_2019_104443 crossref_primary_10_1155_2011_502723 crossref_primary_10_1097_MOO_0b013e328343e811 crossref_primary_10_1017_S0022215117001323 crossref_primary_10_3390_cancers15174201 crossref_primary_10_1002_hed_25599 crossref_primary_10_1001_jamadermatol_2023_1353 crossref_primary_10_1016_j_jaad_2010_11_063 crossref_primary_10_1177_2473974X20984720 crossref_primary_10_1177_0194599818808511 crossref_primary_10_1111_ans_16413 crossref_primary_10_3390_cancers14081871 crossref_primary_10_1016_j_otc_2020_11_012 crossref_primary_10_1002_hed_20576 crossref_primary_10_1111_j_1440_1673_2006_01649_x crossref_primary_10_1016_j_amjoto_2017_01_035 crossref_primary_10_1002_hed_21583 crossref_primary_10_1002_hed_25069 crossref_primary_10_1002_hed_27202 crossref_primary_10_1016_S1041_892X_07_70226_3 crossref_primary_10_3390_curroncol30070487 crossref_primary_10_1002_hed_21965 |
Cites_doi | 10.1002/hed.10063 10.1042/bst0250342 10.1111/j.1600-0560.1996.tb01471.x 10.1038/bjc.1996.642 |
ContentType | Journal Article |
Copyright | Copyright © 2005 Wiley Periodicals, Inc. 2006 INIST-CNRS (c) 2005 Wiley Periodicals, Inc. |
Copyright_xml | – notice: Copyright © 2005 Wiley Periodicals, Inc. – notice: 2006 INIST-CNRS – notice: (c) 2005 Wiley Periodicals, Inc. |
DBID | BSCLL IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 7T5 H94 |
DOI | 10.1002/hed.20321 |
DatabaseName | Istex Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic Immunology Abstracts AIDS and Cancer Research Abstracts |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic AIDS and Cancer Research Abstracts Immunology Abstracts |
DatabaseTitleList | MEDLINE AIDS and Cancer Research Abstracts MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 1097-0347 |
EndPage | 248 |
ExternalDocumentID | 10_1002_hed_20321 16395715 17502430 HED20321 ark_67375_WNG_0GS385SC_V |
Genre | article Journal Article |
GeographicLocations | New Zealand |
GeographicLocations_xml | – name: New Zealand |
GroupedDBID | --- .3N .55 .GA .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 31~ 33P 36B 3O- 3SF 3WU 4.4 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAVGM AAXRX AAZKR ABCQN ABCUV ABEML ABHUG ABIJN ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXME ACXQS ADAWD ADBBV ADBTR ADDAD ADEOM ADIZJ ADKYN ADMGS ADOZA ADZMN ADZOD AEEZP AEIGN AEIMD AEQDE AEQTP AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFVGU AFZJQ AGJLS AHBTC AHMBA AIACR AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BROTX BRXPI BSCLL BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DUUFO EBD EBS EJD EMB EMOBN F00 F01 F04 F5P FEDTE G-S G.N GNP GODZA H.X HBH HF~ HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M6P MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OVD P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RIWAO ROL RWI RX1 RYL SAMSI SUPJJ SV3 TEORI UB1 V2E W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WJL WOHZO WQJ WRC WUP WVDHM WWO WXI WXSBR X7M XG1 XPP XV2 ZGI ZXP ZZTAW ~IA ~WT AITYG HGLYW OIG AAUGY IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 7T5 H94 |
ID | FETCH-LOGICAL-c4231-2813b41f3c1fa9bd1e8c2bd115cf2dbcaae354114e4a83a8f72e8a23f5b4ab193 |
IEDL.DBID | DR2 |
ISSN | 1043-3074 |
IngestDate | Fri Aug 16 10:20:42 EDT 2024 Thu Aug 15 22:45:21 EDT 2024 Fri Aug 23 02:28:06 EDT 2024 Sat Sep 28 07:52:46 EDT 2024 Sun Oct 22 16:04:23 EDT 2023 Sat Aug 24 00:55:35 EDT 2024 Wed Jan 17 05:06:15 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | Human Squamous cell carcinoma Skin disease Parotid gland metastatic Stomatology ENT Malignant tumor Metastasis Immunosuppression SCC immunocompromise Skin Neck parotid |
Language | English |
License | CC BY 4.0 (c) 2005 Wiley Periodicals, Inc. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4231-2813b41f3c1fa9bd1e8c2bd115cf2dbcaae354114e4a83a8f72e8a23f5b4ab193 |
Notes | ArticleID:HED20321 Presented at Australian Society of Head and Neck Surgery Annual Scientific Meeting, Cairns, 2003 istex:09D791C26BDF4C0394E3446E406F659470B8CBB1 ark:/67375/WNG-0GS385SC-V ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
PMID | 16395715 |
PQID | 67656865 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_902333261 proquest_miscellaneous_67656865 crossref_primary_10_1002_hed_20321 pubmed_primary_16395715 pascalfrancis_primary_17502430 wiley_primary_10_1002_hed_20321_HED20321 istex_primary_ark_67375_WNG_0GS385SC_V |
PublicationCentury | 2000 |
PublicationDate | March 2006 |
PublicationDateYYYYMMDD | 2006-03-01 |
PublicationDate_xml | – month: 03 year: 2006 text: March 2006 |
PublicationDecade | 2000 |
PublicationPlace | Hoboken |
PublicationPlace_xml | – name: Hoboken – name: New York, NY – name: United States |
PublicationTitle | Head & neck |
PublicationTitleAlternate | Head Neck |
PublicationYear | 2006 |
Publisher | Wiley Subscription Services, Inc., A Wiley Company John Wiley & Sons |
Publisher_xml | – name: Wiley Subscription Services, Inc., A Wiley Company – name: John Wiley & Sons |
References | Euvard S, Kanitakis J, Pouteil-Noble C, Disant F, Dureau G, Finaz de Villaine J, Claud A, Thivolet J. Aggressive squamous cell carcinoma in organ transplant recipients. Transplant Proc 1995; 27: 1767-1768. Bennett MA, O'Grady A, Kay EW, Leader M, Murphy GM. p53 mutations in squamous cell carcinomas from renal transplant recipients. Biochem Soc Trans 1997; 25: 342-345. Levi F, Randimbison L, Tc VC, La Vecchia C. Non-Hodgkins lymphoma, chronic lymphocytic leukaemias and skin cancers. Br J Cancer 1996; 74: 1847-1850. Weatherall, Ledingham, Warrell. Oxford textbook of medicine, 3rd ed. vol 2. p 2257. O'Brien CJ, McNeil EB, McMahon JD, Pathak I, Lauer CS, Jackson MA. Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland. Head Neck 2002; 24: 417-422. Mihalov ML, Guttuso P, Abraham K, Holmes EW, Reddy V. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single centre. Clin Transplant 1996; 10: 248-255l. Freeman NR, Fourbrother GE, Rose RJ. Survey of skin cancer incidence in the Hamilton area. N Z Med J 1982; 95: 529-533. Khorshid SM, Glover MT, Churchill L, McGregor JM, Proby CM. p53 immunoreactivity in non-melanoma skin cancer from immunosuppressed and immunocompetent individuals: a comparative study of 246 tumours. J Cutan Pathol 1996; 23: 229-233. 2 1996; 74 1995; 27 1982; 95 1996; 10 2002; 24 1997; 25 1996; 23 Weatherall (10.1002/hed.20321-BIB4); 2 Levi (10.1002/hed.20321-BIB6) 1996; 74 Khorshid (10.1002/hed.20321-BIB8) 1996; 23 Mihalov (10.1002/hed.20321-BIB2) 1996; 10 Euvard (10.1002/hed.20321-BIB3) 1995; 27 Bennett (10.1002/hed.20321-BIB7) 1997; 25 Freeman (10.1002/hed.20321-BIB1) 1982; 95 O'Brien (10.1002/hed.20321-BIB5) 2002; 24 |
References_xml | – volume: 74 start-page: 1847 year: 1996 end-page: 1850 article-title: Non‐Hodgkins lymphoma, chronic lymphocytic leukaemias and skin cancers publication-title: Br J Cancer – volume: 10 start-page: 248 year: 1996 end-page: 255l article-title: Incidence of post‐transplant malignancy among 674 solid‐organ‐transplant recipients at a single centre publication-title: Clin Transplant – volume: 2 start-page: 2257 – volume: 25 start-page: 342 year: 1997 end-page: 345 article-title: p53 mutations in squamous cell carcinomas from renal transplant recipients publication-title: Biochem Soc Trans – volume: 23 start-page: 229 year: 1996 end-page: 233 article-title: p53 immunoreactivity in non‐melanoma skin cancer from immunosuppressed and immunocompetent individuals: a comparative study of 246 tumours publication-title: J Cutan Pathol – volume: 95 start-page: 529 year: 1982 end-page: 533 article-title: Survey of skin cancer incidence in the Hamilton area publication-title: N Z Med J – volume: 27 start-page: 1767 year: 1995 end-page: 1768 article-title: Aggressive squamous cell carcinoma in organ transplant recipients publication-title: Transplant Proc – volume: 24 start-page: 417 year: 2002 end-page: 422 article-title: Significance of clinical stage, extent of surgery, and pathologic findings in metastatic cutaneous squamous carcinoma of the parotid gland publication-title: Head Neck – volume: 10 start-page: 248 year: 1996 ident: 10.1002/hed.20321-BIB2 publication-title: Clin Transplant contributor: fullname: Mihalov – volume: 24 start-page: 417 year: 2002 ident: 10.1002/hed.20321-BIB5 publication-title: Head Neck doi: 10.1002/hed.10063 contributor: fullname: O'Brien – volume: 25 start-page: 342 year: 1997 ident: 10.1002/hed.20321-BIB7 publication-title: Biochem Soc Trans doi: 10.1042/bst0250342 contributor: fullname: Bennett – volume: 95 start-page: 529 year: 1982 ident: 10.1002/hed.20321-BIB1 publication-title: N Z Med J contributor: fullname: Freeman – volume: 23 start-page: 229 year: 1996 ident: 10.1002/hed.20321-BIB8 publication-title: J Cutan Pathol doi: 10.1111/j.1600-0560.1996.tb01471.x contributor: fullname: Khorshid – volume: 74 start-page: 1847 year: 1996 ident: 10.1002/hed.20321-BIB6 publication-title: Br J Cancer doi: 10.1038/bjc.1996.642 contributor: fullname: Levi – volume: 27 start-page: 1767 year: 1995 ident: 10.1002/hed.20321-BIB3 publication-title: Transplant Proc contributor: fullname: Euvard – volume: 2 start-page: 2257 volume-title: Oxford textbook of medicine ident: 10.1002/hed.20321-BIB4 contributor: fullname: Weatherall |
SSID | ssj0003642 |
Score | 1.9950867 |
Snippet | Background.
Our aim was to examine the effect of a compromised immune state on the outcomes in patients treated for metastatic cutaneous squamous cell... Our aim was to examine the effect of a compromised immune state on the outcomes in patients treated for metastatic cutaneous squamous cell carcinoma (SCC). A... BACKGROUNDOur aim was to examine the effect of a compromised immune state on the outcomes in patients treated for metastatic cutaneous squamous cell carcinoma... Background. Our aim was to examine the effect of a compromised immune state on the outcomes in patients treated for metastatic cutaneous squamous cell... |
SourceID | proquest crossref pubmed pascalfrancis wiley istex |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 244 |
SubjectTerms | Aged Aged, 80 and over Biological and medical sciences Carcinoma, Squamous Cell - mortality Carcinoma, Squamous Cell - pathology Carcinoma, Squamous Cell - secondary Carcinoma, Squamous Cell - therapy Facial nerve Female Head Head and Neck Neoplasms - mortality Head and Neck Neoplasms - secondary Head and Neck Neoplasms - therapy Hospitals Humans immunocompromise Immunocompromised Host Immunocompromised hosts Logistic Models Male Medical sciences Metastases metastatic Middle Aged Neck Neck Dissection Neoplasm Recurrence, Local - mortality New Zealand - epidemiology Otorhinolaryngology. Stomatology parotid Parotid Gland - surgery Radiotherapy Radiotherapy, Adjuvant Regression analysis Retrospective Studies Risk factors SCC Skin Neoplasms - pathology squamous cell carcinoma Survival |
Title | Effect of immunocompromise on metastatic cutaneous squamous cell carcinoma in the parotid and neck |
URI | https://api.istex.fr/ark:/67375/WNG-0GS385SC-V/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fhed.20321 https://www.ncbi.nlm.nih.gov/pubmed/16395715 https://search.proquest.com/docview/67656865 https://search.proquest.com/docview/902333261 |
Volume | 28 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBYhvfTSB325TVJRSunFiS3JskxOJU2yFJpD07Q5FMRIlsiyxE53bQj59RlZ8S5bGig92QdJWDOS5vM8PhHyXtYlWhaQKeABmQrOitQwXqVOWsuBQxGdOV9P5ORMfDkvzjfI_lgLE_khlg63sDOG8zpscDCLvRVp6IULRJ98KCIPRHoBEH1bUUdxKWKkU_DgXxEjq1DG9pY912zRgyDW65AbCQsUj4_3WvwNeK7j2MEQHT0mv8YpxPyT2W7fmV178we743_O8Ql5dAdQ6ae4op6SDdc8IyaSHNPW02koKGlDJvq8xTXiaNvQS9dBqEyaWmp7RJuu7Rd08buH4FegITZAbbizqGkvgU4biqCTXsG87aY1haamjbOz5-Ts6PD7wSS9u50htQjB8pSpnBuRe25zD5Wpc6csw0deWM9qYwEcLwT-bjkBioPyJXMKGPeFEWAQN74gm03buFeEqqzKfKlqL9FYGgUgvDK2rKTytmSsTsi7UU_6KpJw6Ei3zDSKSA8iSsiHQYPLFjCfhay1stA_T451dnzKVXF6oH8kZGdNxashET0xwbOEvB11rlGQQUpRcjgcwl8li4TQe1pUiIE4QmL8nJdxtayGlyEmmmPnj4PO75-Knhx-Hl5e_3vTN-Rh9A6F9LgtstnNe7eNeKkzO8PGuAUYmBBN |
link.rule.ids | 315,786,790,1382,27957,27958,46329,46753 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaq9gAXHuIVHq2FEOKSduNH4khcUGm7QLsH2kIvyBo7tlitmpTdREL8esZxs6tFVEKckoNtxTMez5fxzGdCXuVVgZ4F8hRwg0wFZzI1jJepy63lwEHGYM7JJB-fi48X8mKDvB1qYSI_xDLgFiyj36-DgYeA9N6KNfS7C0yfPFSRb6G5y_6H6vOKPIrnIp51Ch4iLGLgFRqxvWXXNW-0FQT7M2RHwgIF5OPNFn-DnutItndFh3fJt2ESMQNlttu1Ztf--oPf8X9neY_cucao9F1cVPfJhqsfEBN5jmnj6TTUlDQhGX3e4DJxtKnppWshFCdNLbUdAk7XdAu6-NFBCC3QcDxAbbi2qG4ugU5ririTXsG8aacVhbqitbOzh-T88OBsf5xeX9CQWkRhWcpUxo3IPLeZh9JUmVOW4SOT1rPKWADHpcA_LidAcVC-YE4B414aAQah4yOyWTe1e0KoGpUjX6jK5-gvjQIQXhlblLnytmCsSsjLQVH6KvJw6Mi4zDSKSPciSsjrXoXLFjCfhcS1QuqvkyM9OjrlSp7u6y8J2V7T8WpIBFBM8FFCdgalaxRkkFKUHA6HCFjlMiH0hhYlwiCOqBg_53FcLqvh83AsmmHnN73Sb56KHh-871-e_nvTHXJrfHZyrI8_TD49I7djsChkyz0nm-28cy8QPrVmu7eS3x0iFG8 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELemTUK8wBBfgbFZCCFesjW2kzjiCa3ryleFGIM9IFlnx9aqaklpEwnx13OOl1ZFTEI8JQ-2Fd-dfb-c734m5EVW5uhZIIsBN8hYcJbGmvEitpkxHDikIZjzcZKNz8W7i_Rii7zua2ECP8Qq4OZXRrdf-wU-L93RmjT00nqiT-6LyHdExpk36eHnNXcUz0Q46hTcB1hETys0YEerrhvOaMfL9adPjoQlyseFiy3-hjw3gWzniUZ3yfd-DiEBZXbYNvrQ_PqD3vE_J7lL7lwjVPommNQ9smWr-0QHlmNaOzr1FSW1T0Vf1GgkltYVvbIN-NKkqaGmRbhp63ZJlz9a8IEF6g8HqPGXFlX1FdBpRRF10jks6mZaUqhKWlkze0DORydfjsfx9fUMsUEMlsRMJlyLxHGTOCh0mVhpGD6S1DhWagNgeSrwf8sKkByky5mVwLhLtQCNwPEh2a7qyj4mVA6Kgctl6TL0lloCCCe1yYtMOpMzVkbkea8nNQ8sHCrwLTOFIlKdiCLystPgqgUsZj5tLU_Vt8mpGpyecZmeHauvEdnfUPF6SIRPTPBBRA56nSsUpJdSkBwOh_hXZmlE6A0tCgRBHDExfs6jYC3r4TN_KJpg51edzm-eihqfDLuXJ__e9IDc-jQcqQ9vJ--fktshUuRT5fbIdrNo7TPETo3e79bIb9eCEx4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+immunocompromise+on+metastatic+cutaneous+squamous+cell+carcinoma+in+the+parotid+and+neck&rft.jtitle=Head+%26+neck&rft.au=Southwell%2C+Katherine+E&rft.au=Chaplin%2C+John+M&rft.au=Eisenberg%2C+Robert+L&rft.au=McIvor%2C+Nicholas+P&rft.date=2006-03-01&rft.issn=1043-3074&rft.volume=28&rft.issue=3&rft.spage=244&rft_id=info:doi/10.1002%2Fhed.20321&rft_id=info%3Apmid%2F16395715&rft.externalDocID=16395715 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1043-3074&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1043-3074&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1043-3074&client=summon |